Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Temporal trends in adherence to cardiovascular medications in elderly patients after hospitalization for heart failure.

Setoguchi S, Choudhry NK, Levin R, Shrank WH, Winkelmayer WC.

Clin Pharmacol Ther. 2010 Oct;88(4):548-54. doi: 10.1038/clpt.2010.139. Epub 2010 Sep 8.

PMID:
20827266
2.

Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.

Lamb DA, Eurich DT, McAlister FA, Tsuyuki RT, Semchuk WM, Wilson TW, Blackburn DF.

Circ Cardiovasc Qual Outcomes. 2009 May;2(3):228-35. doi: 10.1161/CIRCOUTCOMES.108.813600. Epub 2009 Apr 28.

3.

Cardiovascular medication utilization and adherence among heart failure patients in rural and urban areas: a retrospective cohort study.

Murphy GK, McAlister FA, Eurich DT.

Can J Cardiol. 2015 Mar;31(3):341-7. doi: 10.1016/j.cjca.2014.11.024. Epub 2014 Nov 28.

PMID:
25633910
4.

Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.

Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.

Am J Cardiol. 2007 Oct 1;100(7):1061-7. Epub 2007 Jul 30.

PMID:
17884362
5.

Impact of restrictive prescription plans on heart failure medication use.

Thanassoulis G, Karp I, Humphries K, Tu JV, Eisenberg MJ, Pilote L.

Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):484-90. doi: 10.1161/CIRCOUTCOMES.108.804351. Epub 2009 Sep 1.

6.

Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.

Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M; French National College of Cardiologists..

Arch Cardiovasc Dis. 2012 Jun-Jul;105(6-7):355-65. doi: 10.1016/j.acvd.2012.04.003. Epub 2012 Jun 28.

7.

How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.

Stuart B, Davidoff A, Erten M, Gottlieb SS, Dai M, Shaffer T, Zuckerman IH, Simoni-Wastila L, Bryant-Comstock L, Shenolikar R.

Health Serv Res. 2013 Dec;48(6 Pt 1):1960-77. doi: 10.1111/1475-6773.12073. Epub 2013 Jun 6.

8.

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.

Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.

J Am Coll Cardiol. 2008 Apr 1;51(13):1247-54. doi: 10.1016/j.jacc.2007.10.063.

9.

Patient adherence to evidence-based pharmacotherapy in systolic heart failure and the transition of follow-up from specialized heart failure outpatient clinics to primary care.

Gjesing A, Schou M, Torp-Pedersen C, Køber L, Gustafsson F, Hildebrandt P, Videbæk L, Wiggers H, Demant M, Charlot M, Gislason GH.

Eur J Heart Fail. 2013 Jun;15(6):671-8. doi: 10.1093/eurjhf/hft011. Epub 2013 Feb 8.

10.

Prevalent but moderate variation across small geographic regions in patient nonadherence to evidence-based preventive therapies in older adults after acute myocardial infarction.

Fang G, Robinson JG, Lauffenburger J, Roth MT, Brookhart MA.

Med Care. 2014 Mar;52(3):185-93. doi: 10.1097/MLR.0000000000000050.

11.

Medication adherence among community-dwelling patients with heart failure.

Dunlay SM, Eveleth JM, Shah ND, McNallan SM, Roger VL.

Mayo Clin Proc. 2011 Apr;86(4):273-81. doi: 10.4065/mcp.2010.0732. Epub 2011 Mar 9.

12.

Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study).

Sueta CA, Rodgers JE, Chang PP, Zhou L, Thudium EM, Kucharska-Newton AM, Stearns SC.

Am J Cardiol. 2015 Aug 1;116(3):413-9. doi: 10.1016/j.amjcard.2015.04.058. Epub 2015 May 8.

13.
14.

Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.

Ivers NM, Schwalm JD, Jackevicius CA, Guo H, Tu JV, Natarajan M.

Can J Cardiol. 2013 Nov;29(11):1408-14. doi: 10.1016/j.cjca.2013.04.009. Epub 2013 Jun 28.

PMID:
23816280
15.

Use of guideline-recommended therapies for heart failure in the Medicare population.

DiMartino LD, Shea AM, Hernandez AF, Curtis LH.

Clin Cardiol. 2010 Jul;33(7):400-5. doi: 10.1002/clc.20760.

16.

National prescribing trends for heart failure medications in children.

Moffett BS, Price JF.

Congenit Heart Dis. 2015 Jan-Feb;10(1):78-85. doi: 10.1111/chd.12183. Epub 2014 Apr 11.

PMID:
24725766
17.

Associations of kidney function with cardiovascular medication use after myocardial infarction.

Winkelmayer WC, Levin R, Setoguchi S.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1415-22. doi: 10.2215/CJN.02010408. Epub 2008 Jul 9.

18.

Medication adherence and Medicare expenditure among beneficiaries with heart failure.

Lopert R, Shoemaker JS, Davidoff A, Shaffer T, Abdulhalim AM, Lloyd J, Stuart B.

Am J Manag Care. 2012 Sep;18(9):556-63.

19.

Adherence to aldosterone-blocking agents in patients with heart failure.

Margolis J, Gerber RA, Roberts C, Gheorghiade M.

Am J Ther. 2010 Sep-Oct;17(5):446-54. doi: 10.1097/MJT.0b013e3181ea3213.

PMID:
20844344
20.

Aldosterone antagonists: the most underutilized class of heart failure medications.

Guglin M, Awad KE, Polavaram L, Vankayala H.

Am J Cardiovasc Drugs. 2007;7(1):75-9.

PMID:
17355168

Supplemental Content

Support Center